Azabicyclo[2.2.1] heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands

Details for Australian Patent Application No. 2010315614 (hide)

Owner Bristol-Myers Squibb Company

Inventors McDonald, Ivar M.; Mate, Robert A.; Cook II, James H.; King, Dalton; Olson, Richard E.; Wang, Nenghui; Iwuagwu, Christiana I.; Zusi, F. Christopher; Hill, Matthew D.; Fang, Haiquan; Macor, John E.

Agent A J Park

Pub. Number AU-A-2010315614

PCT Pub. Number WO2011/056503

Priority 61/255,782 28.10.09 US; 12/907,122 19.10.10 US

Filing date 25 October 2010

Wipo publication date 12 May 2011

International Classifications

C07D 498/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/056503 Priority application(s): WO2011/056503

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010315623-Systems and methods for pipe couplings

2010315611-Multiple orientation battery connector